| 1a. | Re-elect Ronald E. Blaylock - Non-Executive Director | Oppose |
| 1b. | Re-elect Albert Bourla - Chair & Chief Executive | Oppose |
| 1c. | Re-elect Mortimer J. Buckley - Non-Executive Director | Oppose |
| 1d. | Re-elect Susan Desmond-Hellmann - Non-Executive Director | For |
| 1e. | Re-elect Joseph J. Echevarria - Non-Executive Director | Oppose |
| 1f. | Re-elect Scott Gottlieb - Non-Executive Director | For |
| 1g. | Re-elect Dan R. Littman - Non-Executive Director | For |
| 1h. | Re-elect Shantanu Narayen - Senior Independent Director | Oppose |
| 1i. | Re-elect Suzanne Nora Johnson - Non-Executive Director | Oppose |
| 1j. | Re-elect James Quincey - Non-Executive Director | For |
| 1k. | Re-elect James C. Smith - Non-Executive Director | Oppose |
| 1l. | Re-elect Cyrus Taraporevala - Non-Executive Director | For |
| 2. | Re-appoint KPMG LLP as the Auditors of the Company | Oppose |
| 3. | Approve the Amended Pfizer Inc. 2019 Stock Plan | Oppose |
| 4. | Advisory Vote on Executive Compensation | Oppose |
| 5. | Shareholder Resolution: Introduce an Independent Chair Rule | For |
